ReportsnReports.com Says Infectious Disease Diagnostics (IDD) Market research report is segmented by product, application, technology, enduser and region in the forecast period from 2014 to 2019.
Dallas, TX -- (SBWIRE) -- 01/28/2015 -- Increasing Prevalence of deadly infectious disease and need for highly specific & sensitive technologies for rapid diagnosis to drive growth of the IDD Market. The global infectious disease diagnostics (IDD) market report is segmented by product, application, technology, end user and region. The immune diagnostics and polymerase chain reaction technology segments accounted for the lion's share of the global IDD market by technology, owing to the growing need for advanced technologies for rapid diagnosis of infectious diseases. Complete report is available at http://www.reportsnreports.com/reports/323163-infectious-disease-diagnostics-market-by-product-instruments-reagents-services-software-application-hepatitis-c-aids-tuberculosis-technology-pcr-inaat-dna-sequencing-hybridization-end-user-hospital-laboratories-global-forecast-to-2019.html
The infectious disease diagnostics market is segmented on the basis of end user into hospital laboratories, reference labs, physician's office labs, academics and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019. From an insight perspective, this report focuses on qualitative data, market size & the growth of various segments & sub segments, competitive landscape and company profiles. The qualitative data cover various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities and threats), winning imperatives and burning issues.
The IDD market is categorized on the basis of application into the Hepatitis B, Hepatitis C, Human Immuno deficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis & Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA) and others (Influenza, Ebola, Typhoid, Malaria & Dengue, among others). Hospital-acquired MRSA infections, human papilloma virus and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets. The report also offers market sizes and the related growth of various segments in the industry. It focuses on emerging and high-growth segments of the IDD market, high-growth regions and initiatives of the respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=323163
The IDD market is segmented on the basis of product into instruments, consumables (reagents and assays) and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide. The company profiles offer basic views of key players in the IDD market & their product portfolios, recent developments and key strategies adopted. The above mentioned market research data, current market size and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, approaches, R&D investments for innovations in products & technologies and levels of output, in order to remain successful. Priced at US $ 4650 for a single user PDF, a discount on this research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=323163
Few Points From the Table of Contents:
13 Company Profile
13.1 Abbott Laboratories
13.2 Becton, Dickinson & Co.
13.4 Bio-Rad Laboratories
13.5 Alere, Inc.
13.6 Thermo Fisher Scientific, Inc.
13.7 Siemens Healthcare
13.8 Roche Diagnostics
13.9 Danaher Corporation
13.10 Johnson and Johnson
Browse Related Report:
"Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018" research report is now available with ReportsnReports.com. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period are discussed in this research available at http://www.reportsnreports.com/reports/288443-molecular-diagnostics-market-by-application-infectious-disease-oncology-genetics-microbiology-technology-pcr-inaat-dna-sequencing-end-user-hospital-laboratories-product-instruments-reagent-service-software-global-forecasts-to-2018.html
Explore more reports on Medical Devices market
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.